RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.24

EPS Forecast

$155

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
SAGESage Therapeutics IncALKSAlkermes PlcBMRNBiomarin Pharmaceutical IncNKTRNektar TherapeuticsALNYAlnylam Pharmaceuticals IncIONSIonis Pharmaceuticals IncJAZZJazz Pharmaceuticals PlcPAHCPhibro Animal Health CorpSRPTSarepta Therapeutics Inc